Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19

Interim immunogenicity and efficacy data for the Ad26.COV2.S vaccine for COVID-19 have recently been reported(1–3). We describe here the 8-month durability of humoral and cellular immune responses in 20 individuals who received one or two doses of 5×10(10) vp or 10(11) vp Ad26.COV2.S and in 5 partic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:medRxiv
Hlavní autoři: Barouch, Dan H., Stephenson, Kathryn E., Sadoff, Jerald, Yu, Jingyou, Chang, Aiquan, Gebre, Makda, McMahan, Katherine, Liu, Jinyan, Chandrashekar, Abishek, Patel, Shivani, Le Gars, Mathieu, de Groot, Anne Marit, Heerwegh, Dirk, Struyf, Frank, Douoguih, Macaya, van Hoof, Johan, Schuitemaker, Hanneke
Médium: Artigo
Jazyk:Inglês
Vydáno: Cold Spring Harbor Laboratory 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282116/
https://ncbi.nlm.nih.gov/pubmed/34268527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.07.05.21259918
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky